High-density lipoprotein (HDL) is:

Questions 263

ATI RN

ATI RN Test Bank

Pharmacology Across the Lifespan ATI Quizlet Questions

Question 1 of 5

High-density lipoprotein (HDL) is:

Correct Answer: A

Rationale: High-density lipoprotein (HDL) is correctly described in option A as a lipoprotein that contains relatively small amounts of cholesterol and triglycerides and is associated with a decreased risk of atherosclerosis and coronary artery disease. HDL is known as the "good" cholesterol because it helps remove excess cholesterol from the bloodstream and transport it to the liver for excretion. Option B is incorrect because it describes very low-density lipoproteins (VLDLs) that carry cholesterol from the liver to the tissues, not HDL. Option C is incorrect as it describes low-density lipoproteins (LDLs), not HDL. LDLs are considered "bad" cholesterol because they can lead to plaque buildup in the arteries. Option D is inaccurate as it describes chylomicrons that are produced by the small intestine to transport dietary lipids to adipose tissue, not HDL. Understanding the different types of lipoproteins and their roles in cholesterol transport is crucial in pharmacology as it helps in identifying risk factors for cardiovascular diseases and guides treatment strategies. Educating students about the functions of lipoproteins like HDL can enhance their understanding of how medications target these pathways to improve patient outcomes.

Question 2 of 5

Selected liver and muscle enzymes should be monitored during the use of any cholesterol synthesis inhibitors because of possible toxic effects. This consideration is:

Correct Answer: A

Rationale: In pharmacology, monitoring liver and muscle enzymes when using cholesterol synthesis inhibitors is crucial due to the potential for toxic effects. The correct answer is A) TRUE because drugs in this class, like statins, can lead to adverse effects on the liver and muscles, including muscle breakdown (rhabdomyolysis) and liver function abnormalities. Monitoring these enzymes helps detect these issues early. Option B) FALSE is incorrect because ignoring enzyme monitoring could result in serious, sometimes irreversible, harm to the patient. Choosing C) All of the above is incorrect as it implies all options are correct, which is not the case. Option D) None of the above is also incorrect as enzyme monitoring is a standard practice in managing patients on cholesterol synthesis inhibitors. Educationally, understanding the rationale behind enzyme monitoring emphasizes the importance of patient safety in pharmacological interventions. It highlights the need for healthcare professionals to be vigilant in monitoring for potential adverse effects to prevent serious complications. This knowledge ensures safe medication administration and optimal patient outcomes.

Question 3 of 5

Clofibrate (Atromid-S) is generally regarded as superior to gemfibrozil.

Correct Answer: B

Rationale: In the context of pharmacology across the lifespan, understanding the differences between medications like clofibrate and gemfibrozil is crucial for safe and effective patient care. The correct answer, B) FALSE, is supported by current evidence and clinical practice. Clofibrate (Atromid-S) is not regarded as superior to gemfibrozil. Clofibrate has fallen out of favor due to safety concerns and limited efficacy compared to newer lipid-lowering agents. Gemfibrozil, on the other hand, is a more commonly prescribed fibrate that has shown better outcomes in terms of reducing triglycerides and increasing HDL cholesterol levels. Option A) TRUE is incorrect because it incorrectly states that clofibrate is superior, which is not supported by current pharmacological knowledge. Option C) None and D) All the above are also incorrect as they do not provide accurate information regarding the comparative effectiveness of the two drugs. Educationally, this question highlights the importance of staying updated on current pharmacological trends and evidence-based practices. It underscores the need for healthcare professionals to critically evaluate medications to make informed decisions for patient care. Understanding the nuances between medications like clofibrate and gemfibrozil can impact treatment outcomes and patient safety, making this knowledge essential for healthcare providers working across the lifespan.

Question 4 of 5

Which of the following drugs used in the treatment of gout acts by preventing the migration of granulocytes:

Correct Answer: C

Rationale: The correct answer is C) Colchicine. Colchicine is used in the treatment of gout by preventing the migration of granulocytes to the inflamed area, thereby reducing inflammation and pain associated with gout attacks. This mechanism of action makes it an effective drug for managing acute gout episodes. Now let's discuss why the other options are incorrect: A) Allopurinol: Allopurinol is a xanthine oxidase inhibitor that works by reducing the production of uric acid in the body. It does not act by preventing the migration of granulocytes. B) Sulfinpyrazone: Sulfinpyrazone is a uricosuric agent that works by increasing the excretion of uric acid in the urine. It does not prevent the migration of granulocytes. D) Indomethacin: Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting prostaglandin synthesis, thereby reducing inflammation and pain. It does not specifically target the migration of granulocytes. Educational context: Understanding the mechanisms of action of drugs used in the treatment of gout is crucial for nursing students and healthcare professionals to make informed decisions when managing patients with gout. Knowing how each drug works helps in selecting the most appropriate treatment based on the patient's condition and comorbidities. Colchicine's unique mechanism of action in preventing granulocyte migration sets it apart from other medications used in gout management.

Question 5 of 5

Action of vitamin D3 is:

Correct Answer: D

Rationale: The correct answer is D) All of the above. Vitamin D3 plays a crucial role in maintaining calcium and phosphate balance in the body. A) Increased calcium and phosphate absorption by 1,25-dihydroxyvitamin D3 is correct because this active form of vitamin D enhances the absorption of calcium and phosphate in the intestines, promoting bone health. B) Calcium and phosphate excretion may be decreased by 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 is incorrect because vitamin D actually helps to maintain calcium and phosphate levels in the body by promoting absorption rather than excretion. C) Increased calcium and phosphate resorption by 1,25-dihydroxyvitamin D3; bone formation may be increased by 25,24-dihydroxyvitamin D3 is partially correct but not complete. Vitamin D3 is involved in both promoting calcium and phosphate resorption in the kidneys and bones, as well as bone formation. Educational Context: Understanding the action of vitamin D3 is essential in pharmacology as it is commonly prescribed to manage various conditions related to bone health, mineral balance, and overall well-being across the lifespan. Mastery of this concept is crucial for healthcare professionals to provide effective patient care and medication management.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions